in this issue
Regions :: Eastern Europe :: Hungary
Codexis sells its operations in Hungary to US biotech firm Intrexon
11:12 AM MDT | March 14, 2014 | Deepti Ramesh
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, says it has sold its subsidiary and laboratory operations at Budapest, to biotechnology company Intrexon (Germantown, MD), for a purchase price of $1.5 million. The transaction closed on 13 March. No proprietary Codexis materials or intellectual property were included in the transaction, Codexis says. “We were able to transfer our dedicated and talented employees in Hungary to Intrexon and to monetize one of our assets as part of the wind down of our...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee